AP2734A - Pharmaceutical carrier composition and pharmaceutical composition - Google Patents

Pharmaceutical carrier composition and pharmaceutical composition

Info

Publication number
AP2734A
AP2734A AP2009004952A AP2009004952A AP2734A AP 2734 A AP2734 A AP 2734A AP 2009004952 A AP2009004952 A AP 2009004952A AP 2009004952 A AP2009004952 A AP 2009004952A AP 2734 A AP2734 A AP 2734A
Authority
AP
ARIPO
Prior art keywords
composition
pharmaceutical
pharmaceutical carrier
carrier
carrier composition
Prior art date
Application number
AP2009004952A
Other languages
English (en)
Other versions
AP2009004952A0 (en
Inventor
Frans Herwig Jansen
Original Assignee
Dafra Pharma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dafra Pharma Nv filed Critical Dafra Pharma Nv
Publication of AP2009004952A0 publication Critical patent/AP2009004952A0/xx
Application granted granted Critical
Publication of AP2734A publication Critical patent/AP2734A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2009004952A 2007-02-13 2008-02-13 Pharmaceutical carrier composition and pharmaceutical composition AP2734A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2007/001234 WO2008098586A1 (en) 2007-02-13 2007-02-13 Pharmaceutical carrier composition and pharmaceutical composition
PCT/EP2008/001093 WO2008098750A1 (en) 2007-02-13 2008-02-13 Pharmaceutical carrier composition and pharmaceutical composition

Publications (2)

Publication Number Publication Date
AP2009004952A0 AP2009004952A0 (en) 2009-08-31
AP2734A true AP2734A (en) 2013-09-30

Family

ID=38441444

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004952A AP2734A (en) 2007-02-13 2008-02-13 Pharmaceutical carrier composition and pharmaceutical composition

Country Status (6)

Country Link
US (1) US8937085B2 (xx)
EP (1) EP2114372B1 (xx)
AP (1) AP2734A (xx)
CA (1) CA2677856A1 (xx)
WO (2) WO2008098586A1 (xx)
ZA (1) ZA200702602B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397357B1 (it) * 2009-06-26 2013-01-10 Lachifarma Srl Lab Chimico Farmaceutico Salentino Formulazioni in gel in dose fissa a base di derivati dell'artemisinina
WO2015071299A2 (en) * 2013-11-12 2015-05-21 Galenicum Health S.L. Stable pharmaceutical compositions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002217A1 (en) * 1990-08-08 1992-02-20 Ciba-Geigy Ag Antimalarial compositions
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
WO2004075817A2 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Suspendable pharmaceutical composition
WO2006009939A2 (en) * 2004-06-18 2006-01-26 Invacare Corporation System and method for providing a breathing gas
EP1652524A1 (en) * 2003-08-08 2006-05-03 Schering Corporation Dry syrup containing loratadine
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
MXPA03008057A (es) * 2001-03-05 2004-10-15 Johnson & Johnson Composiciones farmaceuticas con sabor oculto.
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US20070275962A1 (en) * 2003-09-10 2007-11-29 Gpc Biotech Ag Heterobicyclic Compounds as Pharmaceutically Active Agents
WO2005026129A1 (en) * 2003-09-15 2005-03-24 Gpc Biotech Ag Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
CN1255106C (zh) * 2003-09-26 2006-05-10 李国桥 复方青蒿素

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002217A1 (en) * 1990-08-08 1992-02-20 Ciba-Geigy Ag Antimalarial compositions
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US6515008B1 (en) * 2000-05-04 2003-02-04 Smithkline Beecham Corporation Formulation
WO2004075817A2 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Suspendable pharmaceutical composition
EP1652524A1 (en) * 2003-08-08 2006-05-03 Schering Corporation Dry syrup containing loratadine
WO2006009939A2 (en) * 2004-06-18 2006-01-26 Invacare Corporation System and method for providing a breathing gas
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions

Also Published As

Publication number Publication date
EP2114372A1 (en) 2009-11-11
AP2009004952A0 (en) 2009-08-31
ZA200702602B (en) 2009-03-25
WO2008098586A1 (en) 2008-08-21
US20100022588A1 (en) 2010-01-28
US8937085B2 (en) 2015-01-20
CA2677856A1 (en) 2008-08-21
EP2114372B1 (en) 2014-05-21
WO2008098750A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
ZA200905224B (en) Pharmaceutical composition
HK1145461A1 (en) Benzodiazepine compound and pharmaceutical composition
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
EP2116242A4 (en) NEW PHARMACEUTICAL COMPOSITION
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
IL205975A0 (en) Pharmaceutical composition
HK1155062A1 (en) Pharmaceutical composition and combined agent
AP2734A (en) Pharmaceutical carrier composition and pharmaceutical composition
EP2114404A4 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION
AP2007004032A0 (en) Pharmaceutical carrier composition and pharmaceutical composition
IL205931A0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition
GB0717036D0 (en) Pharmaceutical composition
GB0612696D0 (en) Pharmaceutical composition